Senti Biosciences Inc.
NASDAQ:SNTI
| Market Cap (Intraday) | 17.33M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.53 |
| 50-Day MA | $0.71 |
| 200-Day MA | $1.13 |
Senti Biosciences Inc. Stock, NASDAQ:SNTI
2 Corporate Drive, First Floor, South San Francisco, California 94080
United States of America
Phone: +1.650.239.2030
Number of Employees: 122
Description
Senti Biosciences, Inc. is a biotechnology company. It engages in the business of developing next-generation cell and gene therapies engineered with a gene circuit platform technology to fight challenging diseases. The company was founded by Timothy K. Lu, Wilson Wong, and Philip Lee on June 9, 2016 and is headquartered in South San Francisco, CA.